Close Menu
The Politic ReviewThe Politic Review
  • Home
  • News
  • United States
  • World
  • Politics
  • Elections
  • Congress
  • Business
  • Economy
  • Money
  • Tech
Trending

WATCH: President Trump and UK Prime Minister Keir Starmer Announce Historic Trade Deal

May 8, 2025

Why Chobani Is A Bright Spot In Dark Times For Dairy Farming

May 8, 2025

The Job Market Is Weird Right Now—Here’s How New Grads Can Still Win

May 8, 2025
Facebook X (Twitter) Instagram
  • Donald Trump
  • Kamala Harris
  • Elections 2024
  • Elon Musk
  • Israel War
  • Ukraine War
  • Policy
  • Immigration
Facebook X (Twitter) Instagram
The Politic ReviewThe Politic Review
Newsletter
Thursday, May 8
  • Home
  • News
  • United States
  • World
  • Politics
  • Elections
  • Congress
  • Business
  • Economy
  • Money
  • Tech
The Politic ReviewThe Politic Review
  • United States
  • World
  • Politics
  • Elections
  • Congress
  • Business
  • Economy
  • Money
  • Tech
Home»Politics»Trump DOJ Asks Court to Dismiss States’ Challenge to FDA Abortion Pill Deregulation
Politics

Trump DOJ Asks Court to Dismiss States’ Challenge to FDA Abortion Pill Deregulation

Press RoomBy Press RoomMay 8, 2025No Comments3 Mins Read
Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram

The Trump administration on Monday filed a motion to dismiss a lawsuit brought by Missouri, Idaho, and Kansas about the Food and Drug Administration’s (FDA) deregulation of the abortion pill.

While Trump’s Department of Justice (DOJ) did not discuss the merits of the case, attorneys contended states lack standing to sue in a Texas court and argued for the case either to be dismissed or transferred to another court.

“Regardless of the merits of the States’ claims, the States cannot proceed in this Court,” the DOJ filing reads.”

“The States are free to pursue their claims in a District where venue is proper, but the States’ claims before this Court must be dismissed or transferred pursuant to the venue statute’s mandatory command,” it reads.

The original lawsuit dates all the way back to November 2022 when pro-life doctors challenged the FDA to prevent rolling back safety restrictions on mifepristone, the first drug used in a two-drug medication abortion regimen. The Supreme Court ultimately dismissed the case in June 2024, ruling that the doctors lacked standing to sue.

The ruling left open the opportunity to states to sue, and Missouri, Idaho, and Kansas ultimately jumped onto pro-life doctors’ already-dismissed lawsuit to continue waging war against the pill.

The lawsuit specifically goes after FDA’s 2016 action extending the permissible gestational age of the baby for which a girl or woman may take abortion drugs from seven weeks gestation to ten weeks gestation, as well as the 2021 rule change allowing abortionists to send mifepristone through the mail, among other changes.

READ MORE: Exclusive — Shocking Data Suggests Abortion Pill Complications 22 Times Higher Than Previously Reported: ‘FDA Must Reinstate Stronger Safeguards’

In a medication abortion, mifepristone — also called by the brand name Mifeprex created by Danco Laboratories — blocks the action of progesterone, which the mother’s body produces to nourish the pregnancy. When progesterone is blocked, the lining of the mother’s uterus deteriorates, and blood and nourishment are cut off to the developing baby, who then dies inside the mother’s womb. The drug misoprostol (also called Cytotec) then causes contractions and bleeding to expel the baby from the mother’s uterus.

In 2023, medication abortions accounted for 63 percent of all abortions within the formal U.S. healthcare system — meaning an estimated 642,700 unborn babies died in medication abortions, according to the pro-abortion Guttmacher Institute. The percentage was up from an estimated 53 percent in 2020 and 39 percent in 2017. The report did not account for abortion pills obtained through underground national and international networks, including those that send pills to women in states with abortion restrictions.

The case is Missouri v. FDA, No. 2:22-cv-223 in the U.S. District Court for the Northern District of Texas. 

Katherine Hamilton is a political reporter for Breitbart News. You can follow her on X @thekat_hamilton



Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link

Related Articles

Politics

Watch Live: Kash Patel Testifies Before House Committee

May 8, 2025
Politics

Photos: First Lady Melania Trump Showcases Blossoming Rose Garden

May 8, 2025
Politics

Report: Ohio Governor Mike DeWine Moves to Block State GOP from Endorsing Vivek Ramaswamy

May 8, 2025
Politics

Canadian Media Struggle to Digest PM Carney’s Chummy Meeting with Trump

May 8, 2025
Politics

Kilmar Abrego Garcia Was Allegedly Hired by Felon to Smuggle Illegals into U.S.

May 8, 2025
Politics

Department of Labor Cuts $13.6 Million in Diversity, Equity, Inclusion Grants for ‘Gender-Expansive People’

May 8, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Why Chobani Is A Bright Spot In Dark Times For Dairy Farming

May 8, 2025

The Job Market Is Weird Right Now—Here’s How New Grads Can Still Win

May 8, 2025

Why California Matters – Activist Post

May 8, 2025

Trump Ceasefire with Houthis Leaves Israel Alone — or Free — to Face Threat

May 8, 2025
Latest News

Watch Live: Kash Patel Testifies Before House Committee

May 8, 2025

The House votes to rename the Gulf of Mexico to Trump's "Gulf of America"

May 8, 2025

Russian exports to US rise sharply – media

May 8, 2025

Subscribe to News

Get the latest politics news and updates directly to your inbox.

The Politic Review is your one-stop website for the latest politics news and updates, follow us now to get the news that matters to you.

Facebook X (Twitter) Instagram Pinterest YouTube
Latest Articles

WATCH: President Trump and UK Prime Minister Keir Starmer Announce Historic Trade Deal

May 8, 2025

Why Chobani Is A Bright Spot In Dark Times For Dairy Farming

May 8, 2025

The Job Market Is Weird Right Now—Here’s How New Grads Can Still Win

May 8, 2025

Subscribe to Updates

Get the latest politics news and updates directly to your inbox.

© 2025 Prices.com LLC. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • For Advertisers
  • Contact

Type above and press Enter to search. Press Esc to cancel.